{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

Nasal Drops Hold Promise in Fighting Deadly Brain Cancer

December 5, 2025The fight against glioblastoma, a deadly brain cancer, has been boosted by new research conducted at Washington University that has developed nasal drops which can travel through nerves found in the nose and reach different parts of our central nervous system in order to fight the glioblastoma cells there. Therapeutics being developed by companies like CNS Pharmaceuticals Inc.


UK Considers Banning Crypto as a Form of Political Donations

December 5, 2025The UK government is considering new rules that could block political parties from accepting donations made in crypto, a move that would directly affect Reform UK only months after it became the first party to take payments in crypto. The global crypto ecosystem, including notable companies like BitMine Immersion Technologies Inc.


NetworkNewsBreaks – Lelantos Holdings, Inc. (OTCID: LNTO) Engages PCAOB-Approved Auditor to Support Planned OTCQB Uplist

December 5, 2025Lelantos Holdings (OTCID: LNTO) has engaged Aloba, Awomolo & Partners, a PCAOB-approved auditing firm, to complete its financial audits as the Company prepares an application to uplist its common stock to the OTCQB Venture Market. AAP will perform independent audits under PCAOB standards to support enhanced transparency, stronger internal controls, and alignment with OTCQB reporting requirements.


Xiaomi Keeps Breaking its Sales Records as Demand Soars for its EVs

December 5, 2025Xiaomi keeps smashing its own electric vehicle sales records as soaring demand pushes its EV business into new territory. The company has now logged its third month in a row with more than 40,000 deliveries, a run that signals how quickly its EV lineup has become a serious force in China’s auto market.


Experts Urge Caution as Bitcoin Starts December on a Losing Streak

December 5, 2025The Fear & Greed Index dropped to 9 in November, its lowest ever in the history of crypto. The expected “Updecember” surge in crypto didn’t happen and many are wondering whether there has been a change in trend or this is a mere market correction before the Bitcoin surge continues.


420 with CNW — New Report Shows Illicit Marijuana is Being Sold as Hemp in Missouri

December 4, 2025A new report from the Missouri Cannabis Trade Association says many retailers that advertise legal hemp products are instead selling cannabis products with high THC levels. The group’s findings come from laboratory tests on 55 products purchased at gas stations, smoke shops, and stores that market themselves as hemp or CBD sellers.


TechMediaBreaks – BluSky AI Inc. (BSAI) Pushing the Boundaries of AI Infrastructure with Neocloud and SkyMod Technology

December 4, 2025As tech giants pour billions into traditional data center expansion, BluSky AI (OTC: BSAI) is uniquely positioned with its innovative Neocloud platform and modular SkyMod technology. “BluSky AI is focused to democratize access to enterprise-grade AI infrastructure through a fundamentally different approach, delivering compute power in months rather than years,” reads a recent article.


TechMediaBreaks – Parler Technologies, Inc. Launches Regulation D 506(c) Offering Ahead of Planned 2026–2027 Uplisting

December 4, 2025Parler Technologies has initiated a Regulation D, Rule 506(c) private placement to raise up to $50 million, with the option to increase to $100 million, ahead of a planned Nasdaq or NYSE public offering targeted for late 2026 or early 2027. Managed by Digital Offering, the raise allows accredited investors to participate in Parler’s rebuilt, fully sovereign technology ecosystem, which includes Triton Cloud, Edgecast CDN, PlayTV, Kyvo, Cartix, and ParlerNews operating on an integrated blockchain protocol layer.


InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) identifies Biomarker Signature Predicting Sensitivity to IV Sapu003

December 4, 2025Oncotelic Therapeutics (OTCQB: OTLC), reports that its 45% owned joint venture, Sapu Nano, has identified a High-RICTOR/Low-RPTOR molecular signature that predicts tumor sensitivity to Sapu003, the company’s intravenous Deciparticle(TM) formulation of everolimus. The biomarker framework, to be presented at the 2025 San Antonio Breast Cancer Symposium, is based on analysis of more than 9,000 tumor samples across 20 cancer types and represents the first prospective selection strategy for IV everolimus.